Fundz

Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer

PUBLIC · COCPJun 03, 2026

Position

Chief Executive Officer

Company

Cocrystal Pharma, Inc.

James Sapirstein
BothellBiotechnologyHealthcareHealth CareTherapeutics

Description

Cocrystal Pharma Inc. has appointed James Sapirstein as Chief Executive Officer, effective immediately. He replaces Sam Lee and Jim Martin, who were serving as Co-Chief Executive Officers.

Quick answer

Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer (June 3, 2026). Cocrystal Pharma, Inc. is based in Bothell, Washington, United States.

Who is the new Chief Executive Officer at Cocrystal Pharma, Inc?
Cocrystal Pharma, Inc. named James Sapirstein Chief Executive Officer, announced June 3, 2026.
What did Cocrystal Pharma, Inc. announce on June 3, 2026?
Cocrystal Pharma Inc. has appointed James Sapirstein as Chief Executive Officer, effective immediately. He replaces Sam Lee and Jim Martin, who were serving as Co-Chief Executive Officers.
What does Cocrystal Pharma, Inc. do?
Cocrystal (OTCQB:COCP) is a pharmaceutical company.
Where is Cocrystal Pharma, Inc. based?
Cocrystal Pharma, Inc. is based in Bothell, Washington, United States.
Which similar companies made leadership changes around the same time?
Change Agents Corporation. (June 4, 2026), Retension Pharmaceuticals (May 27, 2026), Ovid Therapeutics (July 14, 2026) and Jade Biosciences (April 23, 2026) also announced leadership changes within 45 days of Cocrystal Pharma, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Cocrystal Pharma, Inc., and when

A new leader at Cocrystal Pharma, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cocrystal Pharma, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cocrystal Pharma, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cocrystal Pharma, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cocrystal Pharma, Inc.

Location

19805 N. Creek Parkway

Bothell, Washington, United States

About

Cocrystal (OTCQB:COCP) is a pharmaceutical company.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cocrystal Pharma, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Gary
Senior decision-maker at this company
••••••••@••••••••

See Gary's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cocrystal Pharma, Inc.'s next move

Learn about Strategic plan

Cocrystal Pharma, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.